Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Universitätsklinik für Innere Medizin
Klinische Abteilung für Onkologie
SCI/PUBMED gelistet | alle Publikationstypen | Gesamt nach Jahr und Erstautor | MUG-Autor*innen |
** = Publikationen gelistet in SCI/SSCI/Pubmed
Beiträge in Fachzeitschriften
** Aftahy, AK; Barz, M; Lange, N; Baumgart, L; Thunstedt, C; Eller, MA; Wiestler, B; Bernhardt, D; Combs, SE; Jost, PJ; Delbridge, C; Liesche-Starnecker, F; Meyer, B; Gempt, J
The Impact of Postoperative Tumor Burden on Patients With Brain Metastases
FRONT ONCOL. 2022; 12: 869764
Doi: 10.3389/fonc.2022.869764
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Balic, M; Wimmer, K; Suppan, C; Silovski, T; Brunner, C
Expert Discussion: ASCO 2022
BREAST CARE. 2022; 17(4): 430-436.
Doi: 10.1159/000525966
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Balihodzic, A; Prinz, F; Dengler, MA; Calin, GA; Jost, PJ; Pichler, M
Non-coding RNAs and ferroptosis: potential implications for cancer therapy.
Cell Death Differ. 2022; 29(6):1094-1106
Doi: 10.1038/s41418-022-00998-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Barth, DA; Stanzer, S; Spiegelberg, J; Bauernhofer, T; Absenger, G; Posch, F; Lipp, R; Halm, M; Szkandera, J; Balic, M; Gerger, A; Smolle, MA; Hutterer, GC; Klec, C; Jost, PJ; Kargl, J; Stradner, M; Pichler, M
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study.
Cancer Med. 2022; 11(16):3074-3083
Doi: 10.1002/cam4.4675
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Barth, DA; Stanzer, S; Spiegelberg, JA; Bauernhofer, T; Absenger, G; Szkandera, J; Gerger, A; Smolle, MA; Hutterer, GC; Ahyai, SA; Madl, T; Posch, F; Riedl, JM; Klec, C; Jost, PJ; Kargl, J; Stradner, MH; Pichler, M
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study.
Front Immunol. 2022; 13: 840207
Doi: 10.3389/fimmu.2022.840207
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bartsch, R; Balic, M
EVOLUTION OF HER2-TARGETING IN METASTATIC BREAST CANCER
BREAST CARE. 2022;
Doi: 10.1159/000528002
Web of Science
FullText
FullText_MUG
** Bartsch, R; Gampenrieder, SP; Rinnerthaler, G; Petru, E; Egle, D; Petzer, A; Balic, M; Pluschnig, U; Sliwa, T; Singer, C
Updated Austrian treatment algorithm in HER2+metastatic breast cancer
WIEN KLIN WOCHENSCHR. 2022; 134(1-2): 63-72.
Doi: 10.1007/s00508-021-01987-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Baumgart, L; Barz, M; Delbridge, C; Aftahy, AK; Janssen, IK; Jost, PJ; Ryang, YM; Meyer, B; Gempt, J
Spinal Lesions as Clinical Manifestations of Plasma Cell Neoplasia
CURR ONCOL. 2022; 29(9): 6236-6244.
Doi: 10.3390/curroncol29090490
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Blombery, P; Lew, TE; Dengler, MA; Thompson, ER; Lin, VS; Chen, X; Nguyen, T; Panigrahi, A; Handunnetti, SM; Carney, DA; Westerman, DA; Tam, CS; Adams, JM; Wei, AH; Huang, DCS; Seymour, JF; Roberts, AW; Anderson, MA
Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL.
Blood. 2022; 139(8):1198-1207
Doi: 10.1182/blood.2021012775
Web of Science
PubMed
FullText
FullText_MUG
** Brcic, I; Scheipl, S; Bergovec, M; Leithner, A; Szkandera, J; Sotlar, K; Suda, A; Smolle, MA; Kraus, T; Rosenberg, AE; Liegl-Atzwanger, B; Igrec, J
Implementation of Copy Number Variations-Based Diagnostics in Morphologically Challenging EWSR1/FUS::NFATC2 Neoplasms of the Bone and Soft Tissue.
Int J Mol Sci. 2022; 23(24):
Doi: 10.3390/ijms232416196
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Buchacher, L; Richtig, G; Schöffl, C; Richtig, E; Koch, L
Long-term adherence to melanoma follow-up examinations - a telephone survey.
J Eur Acad Dermatol Venereol. 2022; 36(9):e710-e712
Doi: 10.1111/jdv.18177
Web of Science
PubMed
FullText
FullText_MUG
** Dandachi, N; Balic, M
Deciphering the molecular landscape of metastatic lobular breast cancer
EBIOMEDICINE. 2022; 86: 104385
Doi: 10.1016/j.ebiom.2022.104385
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Dankner, M; Wang, Y; Fazelzad, R; Johnson, B; Nebhan, CA; Dagogo-Jack, I; Myall, NJ; Richtig, G; Bracht, JWP; Gerlinger, M; Shinozaki, E; Yoshino, T; Kotani, D; Fangusaro, JR; Gautschi, O; Mazieres, J; Sosman, JA; Kopetz, S; Subbiah, V; Davies, MA; Groover, AL; Sullivan, RJ; Flaherty, KT; Johnson, DB; Benedetti, A; Cescon, DW; Spreafico, A; Zogopoulos, G; Rose, AAN
Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors.
JCO Precis Oncol. 2022; 6:e2200107
Doi: 10.1200/PO.22.00107
PubMed
FullText
FullText_MUG
** Dieckmann, KP; Pokrivcak, T; Geczi, L; Niehaus, D; Dralle-Filiz, I; Matthies, C; Dienes, T; Zschabitz, S; Paffenholz, P; Gschliesser, T; Pichler, R; Mego, M; Bader, P; Zengerling, F; Heinzelbecker, J; Krausewitz, P; Krege, S; Aurilio, G; Aksoy, C; Hentrich, M; Seidel, C; Torzsok, P; Nestler, T; Majewski, M; Hiester, A; Buchler, T; Vallet, S; Studentova, H; Schonburg, S; Niedersuss-Beke, D; Ring, J; Trenti, E; Heidenreich, A; Wulfing, C; Isbarn, H; Pichlmeier, U; Pichler, M
Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study
THER ADV MED ONCOL. 2022; 14: 17588359221086813
Doi: 10.1177/17588359221086813
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Dill, V; Wagner, CV; Keller, EC; Fernandez-Hernandez, FJ; Shoumariyeh, K; Odinius, TO; Buschhorn, L; Hauch, RT; Suren, C; Hecker, JS; Herhaus, P; Sandherr, M; Schmidt, B; Slotta-Huspenina, J; Bassermann, F; Höckendorf, U; Jilg, S; Branca, C; Vosberg, S; Jost, PJ
Elevated RIPK3 correlates with disease burden in myelofibrosis.
Blood Adv. 2022;
Doi: 10.1182/bloodadvances.2021006838
PubMed
FullText
FullText_MUG
** Englisch, C; Konigsbrugge, O; Nopp, S; Moik, F; Quehenberger, P; Preusser, M; Pabinger, I; Ay, C
Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer
INT J MOL SCI. 2022; 23(24): 15770
Doi: 10.3390/ijms232415770
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Englisch, C; Moik, F; Nopp, S; Raderer, M; Pabinger, I; Ay, C
ABO blood group type and risk of venous thromboembolism in patients with cancer
BLOOD ADV. 2022; 6(24): 6274-6281.
Doi: 10.1182/bloodadvances.2021006283
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Fluhrer, H; Hutterer, GC; Golbeck, S; Stidl, M; Niedrist, T; Pichler, R; Mischinger, J; Seles, M; Mannweiler, S; Spiegelberg, J; Bauernhofer, T; Jost, PJ; Ahyai, S; Zigeuner, R; Pichler, M; Barth, DA
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up.
Ther Adv Med Oncol. 2022; 14: 17588359221134065
Doi: 10.1177/17588359221134065
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Gampenrieder, SP; Pircher, M; Fesl, C; Rinnerthaler, G; Mlineritsch, B; Greil-Ressler, S; Steger, GG; Sagaster, V; Fitzal, F; Exner, R; Devyatko, Y; Balic, M; Stöger, H; Suppan, C; Bauernhofer, T; Singer, CF; Pfeiler, G; Seifert, M; Helfgott, R; Heck, D; Rumpold, H; Kwasny, W; Wieder, U; Gnant, M; Greil, R
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Breast Care (Basel). 2022; 17(2):137-145
Doi: 10.1159/000516157
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Gerger, A; Eisterer, W; Fuxius, S; Bastian, S; Koeberle, D; Welslau, M; Sanoyan, DA; Maas, C; Uhlig, J; Fenchel, K; Greil, R; VON, DER, Heyde, E; Agocs, GR; Weide, R; Schwager, M; Reichenbach, F; Modest, DP; Fritsch, R
Retrospective Analysis of Treatment Pathways in Patients With BRAFV600E-mutant Metastatic Colorectal Carcinoma - MORSECRC.
Anticancer Res. 2022; 42(10):4773-4785
Doi: 10.21873/anticanres.15982
Web of Science
PubMed
FullText
FullText_MUG
** Gressenberger, P; Posch, F; Pechtold, M; Gütl, K; Muster, V; Jud, P; Riedl, J; Silbernagel, G; Kolesnik, E; Schmid, J; Raggam, RB; Brodmann, M; Gary, T
Lipoprotein(a) and Pulmonary Embolism Severity-A Retrospective Data Analysis.
Front Cardiovasc Med. 2022; 9: 808605
Doi: 10.3389/fcvm.2022.808605
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hauser, H; Hammer, R; Schollnast, H; Humer-Fuchs, U; Kriegl, D; Fuchsjager, M; Schmidt, F; Balic, M; Lax, SF
Malignant phyllodes tumor of the breast with axillary lymph node metastasis: case report and review of the literature
EUR SURG. 2022;
Doi: 10.1007/s10353-022-00760-0
(- Case Report)
Web of Science
FullText
FullText_MUG
** Heilig, CE; Lassmann, A; Mughal, SS; Mock, A; Pirmann, S; Teleanu, V; Renner, M; Andresen, C; Kohler, BC; Aybey, B; Bauer, S; Siveke, JT; Hamacher, R; Folprecht, G; Richter, S; Schrock, E; Brandts, CH; Ahrens, M; Hohenberger, P; Egerer, G; Kindler, T; Boerries, M; Illert, AL; von Bubnoff, N; Apostolidis, L; Jost, PJ; Westphalen, CB; Weichert, W; Keilholz, U; Klauschen, F; Beck, K; Winter, U; Richter, D; Mohrmann, L; Bitzer, M; Schulze-Osthoff, K; Brors, B; Mechtersheimer, G; Kreutzfeldt, S; Heining, C; Lipka, DB; Stenzinger, A; Schlenk, RF; Horak, P; Glimm, H; Hubschmann, D; Frohling, S
Gene expression-based prediction of pazopanib efficacy in sarcoma
EUR J CANCER. 2022; 172: 107-118.
Doi: 10.1016/j.ejca.2022.05.025
Web of Science
PubMed
FullText
FullText_MUG
** Huemer, M; Jahn-Kuch, D; Hofmann, G; Pichler, M
A case report of immediate effects of acupuncture on neuropathic cancer breakthrough pain.
Complement Ther Clin Pract. 2022; 48: 101599
Doi: 10.1016/j.ctcp.2022.101599
Web of Science
PubMed
FullText
FullText_MUG
** Hutterer, GC; Pichler, M
Renal cell carcinoma-presentation highlights from the ESMO Congress 2021
MEMO-MAG EUR MED ONC. 2022;
Doi: 10.1007/s12254-022-00798-6
Web of Science
FullText
FullText_MUG
** Illini, O; Fabikan, H; Hochmair, MJ; Weinlinger, C; Krenbek, D; Brcic, L; Setinek, U; Terbuch, A; Absenger, G; Konjić, S; Valipour, A
Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study.
J Clin Med. 2022; 11(14):
Doi: 10.3390/jcm11144098
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jahn, A; Rump, A; Widmann, TJ; Heining, C; Horak, P; Hutter, B; Paramasivam, N; Uhrig, S; Gieldon, L; Drukewitz, S; Kubler, A; Bermudez, M; Hackmann, K; Porrmann, J; Wagner, J; Arlt, M; Franke, M; Fischer, J; Kowalzyk, Z; William, D; Weth, V; Oster, S; Frohlich, M; Hullein, J; Gonzalez, CV; Kreutzfeldt, S; Mock, A; Heilig, CE; Lipka, DB; Mohrmann, L; Hanf, D; Oles, M; Teleanu, V; Allgauer, M; Ruhnke, L; Kutz, O; Knurr, A; Lassmann, A; Endris, V; Neumann, O; Penzel, R; Beck, K; Richter, D; Winter, U; Wolf, S; Pfutze, K; Georg, C; Meissburger, B; Buchhalter, I; Augustin, M; Aulitzky, WE; Hohenberger, P; Kroiss, M; Schirmacher, P; Schlenk, RF; Keilholz, U; Klauschen, F; Folprecht, G; Bauer, S; Siveke, JT; Brandts, CH; Kindler, T; Boerries, M; Illert, AL; von Bubnoff, N; Jost, PJ; Metzeler, KH; Bitzer, M; Schulze-Osthoff, K; von Kalle, C; Brors, B; Stenzinger, A; Weichert, W; Hubschmann, D; Frohling, S; Glimm, H; Schrock, E; Klink, B
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers
ANN ONCOL. 2022; 33(11): 1186-1199.
Doi: 10.1016/j.annonc.2022.07.008
Web of Science
PubMed
FullText
FullText_MUG
** Jahn, SW; Jost, PJ
Challenges in integrating molecular profiles into clinical cancer care
MEMO-MAG EUR MED ONC. 2022;
Doi: 10.1007/s12254-022-00838-1
Web of Science
FullText
FullText_MUG
** Juracek, J; Madrzyk, M; Stanik, M; Ruckova, M; Trachtova, K; Malcikova, H; Lzicarova, E; Barth, DA; Pichler, M; Slaby, O
A tissue miRNA expression pattern is associated with disease aggressiveness of localized prostate cancer
PROSTATE. 2022;
Doi: 10.1002/pros.24466
Web of Science
PubMed
FullText
FullText_MUG
** Khorana, AA; Mackman, N; Falanga, A; Pabinger, I; Noble, S; Ageno, W; Moik, F; Lee, AYY
Cancer-associated venous thromboembolism.
Nat Rev Dis Primers. 2022; 8(1): 11
Doi: 10.1038/s41572-022-00336-y
Web of Science
PubMed
FullText
FullText_MUG
** Klec, C; Knutsen, E; Schwarzenbacher, D; Jonas, K; Pasculli, B; Heitzer, E; Rinner, B; Krajina, K; Prinz, F; Gottschalk, B; Ulz, P; Deutsch, A; Prokesch, A; Jahn, SW; Lellahi, SM; Perander, M; Barbano, R; Graier, WF; Parrella, P; Calin, GA; Pichler, M
ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform.
Cell Mol Life Sci. 2022; 79(7): 391
Doi: 10.1007/s00018-022-04402-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Klocker, EV; Balic, M; Steger, G
Molecular profiling leading to personalized treatment in breast cancer
MEMO-MAG EUR MED ONC. 2022;
Doi: 10.1007/s12254-021-00792-4
Web of Science
FullText
FullText_MUG
** Krstic, J; Reinisch, I; Schindlmaier, K; Galhuber, M; Riahi, Z; Berger, N; Kupper, N; Moyschewitz, E; Auer, M; Michenthaler, H; Nössing, C; Depaoli, MR; Ramadani-Muja, J; Usluer, S; Stryeck, S; Pichler, M; Rinner, B; Deutsch, AJA; Reinisch, A; Madl, T; Chiozzi, RZ; Heck, AJR; Huch, M; Malli, R; Prokesch, A
Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism.
Sci Adv. 2022; 8(3):eabh2635
Doi: 10.1126/sciadv.abh2635
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lindner, AK; Pichler, M; Thurnher, M; Pichler, R
Targeting c-Met to Improve Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma.
Eur Urol. 2022; 81(1): 1-2.
Doi: 10.1016/j.eururo.2021.10.025
Web of Science
PubMed
FullText
FullText_MUG
** Maisel, F; Smolle, MA; Mollnar, S; Riedl, JM; Barth, DA; Seles, M; Terbuch, A; Rossmann, CH; Eisner, F; Mannweiler, S; Hutterer, G; Zigeuner, R; Pummer, K; Smolle-Jüttner, FM; Lindenmann, J; Stotz, M; Gerger, A; Jost, PJ; Bauernhofer, T; Pichler, M; Posch, F
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis.
Clin Genitourin Cancer. 2022; 20(4):344-353
Doi: 10.1016/j.clgc.2022.03.010
Web of Science
PubMed
FullText
FullText_MUG
** Meinhardt, AL; Munkhbaatar, E; Höckendorf, U; Dietzen, M; Dechant, M; Anton, M; Jacob, A; Steiger, K; Weichert, W; Brcic, L; McGranahan, N; Branca, C; Kaufmann, T; Dengler, MA; Jost, PJ
The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner.
Oncogene. 2022; 41(9):1376-1382
Doi: 10.1038/s41388-021-02161-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Minichsdorfer, C; Fuereder, T; Leutner, M; Singer, CF; Kacerovsky-Strobl, S; Egle, D; Greil, R; Balic, M; Fitzal, F; Pfeiler, G; Frantal, S; Bartsch, R; Gnant, M
Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18.
ESMO Open. 2022; 7(2):100426
Doi: 10.1016/j.esmoop.2022.100426
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Mischinger, J; Schöllnast, H; Zurl, H; Geyer, M; Fischereder, K; Adelsmayr, G; Igrec, J; Fritz, G; Merdzo-Hörmann, M; Elstner, J; Schmid, J; Triebl, A; Trimmel, V; Reiter, C; Steiner, J; Rosenlechner, D; Seles, M; Pichler, GP; Pichler, M; Riedl, J; Schöpfer-Schwab, S; Strobl, J; Hutterer, GC; Zigeuner, R; Pummer, K; Augustin, H; Ahyai, S; Mannweiler, S; Fuchsjäger, M; Talakic, E
Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients.
Front Surg. 2022; 9: 1013389
Doi: 10.3389/fsurg.2022.1013389
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moik, F; Ay, C
Venous and arterial thromboembolism in patients with cancer treated with targeted anti-cancer therapies
THROMB RES. 2022; 213: S58-S65.
Doi: 10.1016/j.thromres.2022.01.004
Web of Science
FullText
FullText_MUG
** Moik, F; Ay, C
Hemostasis and cancer: Impact of haemostatic biomarkers for the prediction of clinical outcomes in patients with cancer
J THROMB HAEMOST. 2022;
Doi: 10.1111/jth.15880
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moik, F; Colling, M; Mahé, I; Jara-Palomares, L; Pabinger, I; Ay, C
Extended anticoagulation treatment for cancer-associated thrombosis-Rates of recurrence and bleeding beyond 6 months: A systematic review.
J THROMB HAEMOST. 2022; 20(3): 619-634.
Doi: 10.1111/jth.15599
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pelzmann, B; Hatab, A; Scheruebel, S; Langthaler, S; Rienmueller, T; Sokolowski, A; Gorischek, A; Platzer, D; Zorn-Pauly, K; Jahn, SW; Bauernhofer, T; Schreibmayer, W
Consequences of somatic mutations of GIRK1 detected in primary malign tumors on expression and function of G-protein activated, inwardly rectifying, K+ channels
FRONT ONCOL. 2022; 12: 998907
Doi: 10.3389/fonc.2022.998907
Web of Science
FullText
FullText_MUG
** Pichler, M
Best of ASCO 2022-bladder cancer
MEMO-MAG EUR MED ONC. 2022;
Doi: 10.1007/s12254-022-00847-0
Web of Science
FullText
FullText_MUG
** Posch, F; Niedrist, T; Glantschnig, T; Firla, S; Moik, F; Kolesnik, E; Wallner, M; Verheyen, N; Jost, PJ; Zirlik, A; Pichler, M; Balic, M; Rainer, PP
Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer.
Front Cardiovasc Med. 2022; 9: 933428
Doi: 10.3389/fcvm.2022.933428
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pototschnig, I; Feiler, U; Diwoky, C; Vesely, PW; Rauchenwald, T; Paar, M; Bakiri, L; Pajed, L; Hofer, P; Kashofer, K; Sukhbaatar, N; Schoiswohl, G; Weichhart, T; Hoefler, G; Bock, C; Pichler, M; Wagner, EF; Zechner, R; Schweiger, M
Interleukin-6 initiates muscle- and adipose tissue wasting in a novel C57BL/6 model of cancer-associated cachexia
J CACHEXIA SARCOPENI. 2022;
Doi: 10.1002/jcsm.13109
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pratsinis, M; Fankhauser, C; Pratsinis, K; Beyer, J; Bührer, E; Cathomas, R; Fischer, N; Hermanns, T; Hirschi-Blickenstorfer, A; Kamradt, J; Alex, Kluth, L; Zihler, D; Mingrone, W; Müller, B; Nestler, T; Rothschild, SI; Seifert, B; Templeton, AJ; Terbuch, A; Ufen, MP; Woelky, R; Gillessen, S; Rothermundt, C
Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses.
Eur Urol Open Sci. 2022; 40: 16-18.
Doi: 10.1016/j.euros.2022.03.013
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Prinz, F; Jonas, K; Balihodzic, A; Klec, C; Reicher, A; Barth, DA; Riedl, J; Gerger, A; Kiesslich, T; Mayr, C; Rinner, B; Kargl, J; Pichler, M
MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon response.
RNA Biol. 2022; 19(1):1305-1315
Doi: 10.1080/15476286.2022.2152978
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Reissig, TM; Uhrig, S; Jost, PJ; Luchini, C; Vicentini, C; Liffers, ST; Allgauer, M; Adsay, V; Scarpa, A; Lawlor, RT; Frohling, S; Stenzinger, A; Kloppel, G; Schildhaus, HU; Siveke, JT
MCL1 as putative target in pancreatoblastoma
VIRCHOWS ARCH. 2022;
Doi: 10.1007/s00428-022-03349-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Remschmidt, B; Gaessler, J; Brcic, L; Wallner, J; Muallah, D; Rieder, M
The impact of COVID-19 on oral squamous cell carcinoma's diagnostic stage-A retrospective study.
Oral Dis. 2022;
Doi: 10.1111/odi.14441
Web of Science
PubMed
FullText
FullText_MUG
** Riedl, JM; Schwarzenbacher, E; Moik, F; Horvath, L; Gantschnigg, A; Renneberg, F; Posch, F; Barth, DA; Stotz, M; Pichler, M; Hatzl, S; Fandler-Höfler, S; Gressenberger, P; Gary, T; Jost, PJ; Greil, R; Ay, C; Djanani, A; Gerger, A; Schlick, K
Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel.
Thromb Haemost. 2022; 122(4):633-645
Doi: 10.1055/a-1548-4847
Web of Science
PubMed
FullText
FullText_MUG
** Rinnerthaler, G; Singer, C; Petru, E; Egle, D; Petzer, A; Pluschnig, U; Gampenrieder, SP; Pfeiler, G; Gnant, M; Grunberger, B; Krippl, P; Strasser-Weippl, K; Suppan, C; Brunner, C; Pusch, R; Sandholzer, M; Balic, M; Bartsch, R
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update
WIEN KLIN WOCHENSCHR. 2022;
Doi: 10.1007/s00508-022-02082-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sanfilippo, KM; Moik, F; Candeloro, M; Ay, C; Di Nisio, M; Lee, AYY
Unanswered questions in cancer-associated thrombosis
BRIT J HAEMATOL. 2022;
Doi: 10.1111/bjh.18276
Web of Science
PubMed
FullText
FullText_MUG
** Schlintl, V; Huemer, F; Rinnerthaler, G; Melchardt, T; Winder, T; Reimann, P; Riedl, J; Amann, A; Eisterer, W; Romeder, F; Piringer, G; Ilhan-Mutlu, A; Woll, E; Greil, R; Weiss, L
Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort
BMC CANCER. 2022; 22(1): 51
Doi: 10.1186/s12885-021-09115-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Seidel, MG; Kashofer, K; Moser, T; Thueringer, A; Liegl-Atzwanger, B; Leithner, A; Szkandera, J; Benesch, M; El-Heliebi, A; Heitzer, E
Clinical implementation of plasma cell-free circulating tumor DNA quantification by digital droplet PCR for the monitoring of Ewing sarcoma in children and adolescents.
Front Pediatr. 2022; 10: 926405
Doi: 10.3389/fped.2022.926405
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Singer, CF; Holst, F; Steurer, S; Burandt, EC; Lax, SF; Jakesz, R; Rudas, M; Stoger, H; Greil, R; Sauter, G; Filipits, M; Simon, R; Gnant, M; Abcsg, ABCSG
Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer
CLIN CANCER RES. 2022; 28(18): 4112-4120.
Doi: 10.1158/1078-0432.CCR-21-4328
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Smolle, MA; Musser, E; Bergovec, M; Friesenbichler, J; Wibmer, CL; Leitner, L; Sørensen, MS; Petersen, MM; Brcic, I; Szkandera, J; Scheipl, S; Leithner, A
Survival Prediction in Patients Treated Surgically for Metastases of the Appendicular Skeleton-An External Validation of 2013-SPRING Model.
Cancers (Basel). 2022; 14(14):
Doi: 10.3390/cancers14143521
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Suppan, C
ESMO 2021-my top three abstracts in breast cancer
MEMO-MAG EUR MED ONC. 2022;
Doi: 10.1007/s12254-022-00810-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Suppan, C; Graf, R; Jahn, S; Zhou, Q; Klocker, EV; Bartsch, R; Terbuch, A; Kashofer, K; Regitnig, P; Lindenmann, J; Posch, F; Gerritsmann, H; Jost, PJ; Heitzer, E; Dandachi, N; Balic, M
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients.
Br J Cancer. 2022; 126(3):456-463
Doi: 10.1038/s41416-021-01601-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Szkandera, J
Keeping up the 'race pace' in a patient with nonuterine leiomyosarcoma
FUTURE ONCOL. 2022;
Doi: 10.2217/fon-2022-0636
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Terbuch, A; Absenger, G
Neoadjuvant treatment in non-small-cell lung cancer-the earlier, the better
MEMO-MAG EUR MED ONC. 2022;
Doi: 10.1007/s12254-022-00828-3
Web of Science
FullText
FullText_MUG
** Terbuch, A; Posch, F; Bauernhofer, T; Jost, PJ; Partl, R; Stranzl-Lawatsch, H; Baciarello, G; Fizazi, K; Giannatempo, P; Verzoni, E; Sweeney, C; Ravi, P; Tran, B; Basso, U; White, J; Vincenzi, B; Oing, C; Cutuli, HJ; Dieckmann, KP; Gamulin, M; Chovanec, M; Fankhauser, CD; Heidenreich, A; Mohamad, O; Thibault, C; Fischer, S; Gillessen, S, , International, Germ, Cell, Cancer, Collaborative, Group
Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2022; 113(4):825-832
Doi: 10.1016/j.ijrobp.2022.03.021
Web of Science
PubMed
FullText
FullText_MUG
** Uhl, B; Prochazka, KT; Pansy, K; Wenzl, K; Strobl, J; Baumgartner, C; Szmyra, MM; Waha, JE; Wolf, A; Tomazic, PV; Steinbauer, E; Steinwender, M; Friedl, S; Weniger, M; Küppers, R; Pichler, M; Greinix, HT; Stary, G; Ramsay, AG; Apollonio, B; Feichtinger, J; Beham-Schmid, C; Neumeister, P; Deutsch, AJ
Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter's Trans-Formed DLBCL and Germinal Center B-Cells.
Int J Mol Sci. 2022; 23(14):
Doi: 10.3390/ijms23147874
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wahida, A; Buschhorn, L; Frohling, S; Jost, PJ; Schneeweiss, A; Lichter, P; Kurzrock, R
The coming decade in precision oncology: six riddles
NAT REV CANCER. 2022;
Doi: 10.1038/s41568-022-00529-3
Web of Science
PubMed
FullText
FullText_MUG
** Westphal, T; Gampenrieder, SP; Rinnerthaler, G; Balic, M; Posch, F; Dandachi, N; Hauser-Kronberger, C; Reitsamer, R; Sotlar, K; Radl, B; Suppan, C; Stöger, H; Greil, R
Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer - Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT).
Breast Care (Basel). 2022; 17(1): 1-9.
Doi: 10.1159/000512467
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Wirth, AK; Wange, L; Vosberg, S; Henrich, KO; Rausch, C; Özdemir, E; Zeller, CM; Richter, D; Feuchtinger, T; Kaller, M; Hermeking, H; Greif, PA; Senft, D; Jurinovic, V; Bahrami, E; Jayavelu, AK; Westermann, F; Mann, M; Enard, W; Herold, T; Jeremias, I
In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistance.
Leukemia. 2022; 36(12):2863-2874
Doi: 10.1038/s41375-022-01726-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zhou, Q; Gampenrieder, SP; Frantal, S; Rinnerthaler, G; Singer, CF; Egle, D; Pfeiler, G; Bartsch, R; Wette, V; Pichler, A; Petru, E; Dubsky, PC; Bago-Horvath, Z; Fesl, C; Rudas, M; Ståhlberg, A; Graf, R; Weber, S; Dandachi, N; Filipits, M; Gnant, M; Balic, M; Heitzer, E
Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response.
Clin Cancer Res. 2022; 28(4):697-707
Doi: 10.1158/1078-0432.CCR-21-3231
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Huemer, M
Möglichkeiten zur Verbesserung der Lebensqualität - Was macht Sinn, was nicht?.
Spectrum Onkologie. 2022; 2022(06): 12-14.
FullText
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
** Allmendinger, F; Agrawal, D; Dietzen, M; Vosberg, S; Munkhbaatar, E; McGranahan, N; Jost, P
Inflammatory cell death acts as tumor suppressor in lung adenocarcinoma
INTERNIST. 2022; 63(SUPPL 3):338-339.
[Oral Communication]
Web of Science
** Balic, M; Posch, F; Bartsch, R
Phase II Study of Neratinib and Trastuzumab plus -oral Vinorelbine in previously treated metastatic Her2 positive Breast Cancer
ONCOL RES TREAT. 2022; 45(SUPPL 2): 106-106.
[Poster]
Web of Science
** Bonnin-Gruber, Y; Schroder, J; Forstbauer, H; Kisro, J; Welslau, M; Muller-Huesmann, H; Burkle, D; Krammer-Steiner, B; von der Heyde, E; Reichenbach, F; Arnold, D; Fritsch, R; Gerger, A; Hegewisch-Becker, S; Vogel, A; Winder, T; Koeberle, D; Prager, G; Stintzing, S
Patient characteristics at baseline in the BERING CRC study: real-world data on BRAF V600E-mutated metastatic colorectal cancer
ONCOL RES TREAT. 2022; 45(SUPPL 2): 315-316.
[Poster]
Web of Science
** Brcic, L; Zacharias, M; Konjic, S; Kashofer, K; Absenger, G; Jost, PJ; Wurm, R; Lindenmann, J; Terbuch, A
Molecular testing in lung squamous cell carcinoma using DNA- and RNA-based next-generation sequencing: A singlecenter experience
ANN ONCOL. 2022; 38(9): S1557-S1557.
Doi: 10.1016/j.annonc.2022.10.344
[Poster]
Web of Science
FullText
FullText_MUG
** Dutta, S; Kerbs, P; Rothenberg-Thurley, M; Ksienzyk, B; Krebs, S; Blum, H; Spiekermann, K; Metzeler, KH; Herold, T; Vosberg, S; Greif, PA
Acute Myeloid Leukemia with Isolated Trisomy 4 Is Characterized By Frequent Mutations of TET2 and a Distinct DNA Methylation Signature
BLOOD. 2022; 140: 8912-8913.
Doi: 10.1182/blood-2022-168939
Web of Science
FullText
FullText_MUG
** El-Heliebi, A; Prietl, B; Mahdy-Ali, K; Purkart, TU; Gerlitz, L; Skofler, C; Stanzer, S; Franz, J; Harbusch, N; Madl, T; Widhalm, G; Rossler, K; Tomberger, M; Mattersdorfer, K; Kroneis, T; Oberhuber, M; Pieber, TR
Next generation drug screening platform: generation of patient-derived cells for ex vivo drug response studies of gliomas
NEURO-ONCOLOGY. 2022; 24: -Brain Tumor Meeting 2022; May 19-20, 2022; Berlin, GERMANY.
Doi: 10.1093/neuonc/noac174.180
[Poster]
Web of Science
FullText
FullText_MUG
** Englisch, C; Konigsbrugge, O; Moik, F; Quehenberger, P; Preusser, M; Pabinger, I; Ay, C
Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer
THROMB RES. 2022; 213: S12-S12.-11th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC); MAY 27-29, 2022; Bergamo, ITALY.
[Oral Communication]
Web of Science
** Fischer, S; Rothermundt, C; Stalder, O; Terbuch, A; Hermanns, T; Zihler, D; Muller, B; Hirschi-Blickenstorfer, A; Seifert, B; Kluth, LA; Ufe, MP; Mingrone, W; Templeton, A; Fischer, N; Rothschild, S; Beyer, J; Woelky, R; Gillessen, S; Cathomas, R
Importance of tumor markers in the detection of recurrences - Findings from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS)
ONCOL RES TREAT. 2022; 45(SUPPL 2):209-209.-DGHO 2022;
[Poster]
Web of Science
** Harbeck, N; Wrobel, D; Zaiss, M; Guth, D; Distelrath, A; Terhaag, J; Lorenz, A; Bartsch, R; Breitenstein, U; Schwitter, M; Balic, M; Jackisch, C; Muller, V; Rinnerthaler, G; Schmidt, M; Zaman, K; Schinkothe, T; Luftner, D
Interim analysis (n=150) of the multi-national, prospective, non-interventional ELEANOR study observing real-life extended adjuvant treatment with neratinib in patients with HER2+/ HR+ early breast cancer (eBC)
ANN ONCOL. 2022; 33: S157-S157.
Doi: 10.1016/j.annonc.2022.03.091
[Poster]
Web of Science
FullText
FullText_MUG
** Heinemann, V; von Weikersthal, LF; Fuchs, M; Kaiser, F; Heinrich, K; Modest, D; Hofheinz, R; Decker, T; Gerger, A; Angermeier, S; Rumpold, H; Dickhut, A; Ohler, L; Grunberger, B; Niedersuss-Beke, D; Sandmann, M; Kasper, S; Prager, G; Stintzing, S
FIRE-4 (AIO-KRK-0114): Randomized study for a switch maintenance concept with 5-FU plus bevacizumab after induction treatment with FOLFIRI plus cetuximab versus continued treatment with FOLFIRI plus cetuximab - secondary endpoint
ANN ONCOL. 2022; 33: S363-S364.
Doi: 10.1016/j.annonc.2022.04.415
[Poster]
Web of Science
FullText
FullText_MUG
** Hochmair, M; Absenger, G; Ay, L; Robinson, I; Jansen, C; Sladek, B; Knabl, A; Gasche, N; Valipou, A
Introducing "BiomeOne" a Microbiome-based bBiomarker to Predict Immune Checkpoint Inhibitor Response in NSCLC 1patients
J THORAC ONCOL. 2022; 17(9): S561-S561.
[Poster]
Web of Science
** Hochmair, M; Schmidinger, M; Ay, L; Robinson, I; Absenger, G; Pichler, M; Nguyen, VA; Richtig, E; Rainer, B; Jansen, C; Sladek, B; Knabl, A; Gasche, N; Valipour, A
BiomeOne: multi-center Validation of a new microbiome-based Biomarker to predict Response to Cancer Immunotherapy
ONCOL RES TREAT. 2022; 45(SUPPL 2):229-229.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; Okt 7-10, 2022; Wien.
[Poster]
Web of Science
** Illini, O; Fabikan, H; Hochmair, MJ; Weinlinger, C; Krenbek, D; Brcic, L; Setinek, U; Terbuch, A; Absenger, G; Konji, S; Valipour, A
Characteristics and treatment outcomes in advanced stage non-small cell lung cancer patients with KRAS G12C mutation
WIEN KLIN WOCHENSCHR. 2022; 134(19-20):727-728.
Web of Science
** Keller, EC; Jost, PJ; Schwamborn, K; Weichert, W; Horn, T; Slotta-Huspenina, J
Mixed Lineage Kinase Domain-like Protein (MLKL) in Primary Resected Bladder Cancer: Expression, Prognostic Role and Correlations with the Immune Environment
LAB INVEST. 2022; 102(SUPPL 1): 613-613.
[Poster]
Web of Science
** Keller, EC; Jost, PJ; Schwamborn, K; Weichert, W; Horn, T; Slotta-Huspenina, J
Mixed Lineage Kinase Domain-like Protein (MLKL) in Primary Resected Bladder Cancer: Expression, Prognostic Role and Correlations with the Immune Environment
MODERN PATHOL. 2022; 35(SUPPL 2): 613-613.
[Poster]
Web of Science
** Lembeck, A; Zebisch, A; Quehenberger, F; Wolfler, A
Pravalenz von Pilz- und Fisch-formigen Erythrozyten in verschiedenen hamatologischen Erkrankungen
ONCOL RES TREAT. 2022; 45(SUPPL 2):290-291.
[Poster]
Web of Science
** Luftner, D; Bartsch, R; Breitenstein, U; Balic, M; Jackisch, C; Muller, V; Rinnerthaler, G; Schmidt, M; Schwitter, M; Zaman, K; Wrobel, D; Guth, D; Terhaag, J; Zaiss, M; Distelrath, A; Lorenz, A; Schinkothe, T; Harbeck, N
Interim analysis (n=150) of the multi-national, prospective, non-interventional ELEANOR study observing real-life extended adjuvant treatment with neratinib in patients with HER2+/ HR+ early breast cancer (eBC)
ONCOL RES TREAT. 2022; 45(SUPPL 3): 20-21.
[Poster]
Web of Science
** Marme, F; Hanusch, C; Furlanetto, J; Morris, P; Link, T; Denkert, C; Fasching, PA; Jackisch, C; Antolin, S; Solbach, C; Aftimos, P; Huober, J; Untch, M; Balic, M; Reinisch, M; Blohmer, JU; Concalves, A; Rey, J; Buchele, T; Loibl, S
Safety interim analysis (SIA) of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan (SG) in patients (pts) with primary HER2-negative breast cancer (BC) at high relapse risk after neoadjuvant chemotherapy (NACT)
ONCOL RES TREAT. 2022; 45(SUPPL 3): 30-30.
[Poster]
Web of Science
** Marme, F; Hanusch, C; Furlanetto, J; Morris, P; Link, T; Denkert, C; Fasching, PA; Jackisch, C; Antolin, S; Solbach, C; Aftimos, P; Huober, J; Untch, M; Balic, M; Reinisch, M; Blohmer, JU; Goncalves, A; Rey, J; Buchele, T; Loibl, S
Safety interim analysis (SIA) of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan (SG) in patients with primary HER2-negative breast cancer (BC) at high relapse risk after neoadjuvant treatment
ANN ONCOL. 2022; 33: S148-S149.
Doi: 10.1016/j.annonc.2022.03.074
[Poster]
Web of Science
FullText
FullText_MUG
** Moik, F; Kraler, S; Montecucco, F; Liberale, L; Nopp, S; Englisch, C; Lapikova-Bryhinska, T; Akhmedov, A; von Eckardstein, A; Wenzl, FA; Pabinger, I; Luscher, TF; Ay, C
Cardiovascular Biomarkers for the Prediction of Adverse Cardiovascular Events and Mortality in Patients with Cancer
BLOOD. 2022; 140: 1255-1256.
Doi: 10.1182/blood-2022-163287
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Moik, F; Riedl, J; Barth, D; Chan, WSE; Wiedemann, S; Holler, C; Fuereder, T; Jost, P; Pabinger, I; Preusser, M; Ay, C
Early Dynamics of C-Reactive Protein Predict Risk of Venous Thromboembolism in Patients with Cancer Treated with Immune Checkpoint Inhibitors
BLOOD. 2022; 140: 1250-1251.
Doi: 10.1182/blood-2022-160087
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Pfeiler, G; Hlauschek, D; Mayer, EL; Deutschmann, C; Kacerovsky-Strobl, S; Martin, M; Meisel, JL; Zdenkowski, N; Loibl, S; Balic, M; Park, H; Prat, A; Isaacs, C; Machacek-Link, J; Schurmans, C; Theall, KP; Fesl, C; Dueck, AC; DeMichele, A; Gnant, M
Impact of body mass index on treatment and outcomes in patients with early hormone receptor-positive breast cancer receiving endocrine therapy with or without palbociclib in the PALLAS trial.
J CLIN ONCOL. 2022; 40(16):
[Poster]
Web of Science
** Prager, G; Hubner, G; Schroder, J; Forstbauer, H; Kisro, J; Welslau, M; Burkle, D; Von der Heyde, E; Muller-Huesmann, H; Krammer-Steiner, B; Hering-Schubert, C; Popper, U; Gerger, A; Greil, R; Reichenbach, F; Arnold, D; Fritsch, R; Hegewisch-Becker, S; Vogel, A; Wagner, AD; Winder, T; Koeberle, D; Stintzing, S
Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma: a multi-centric, multi-national, prospective, non-interventional study in Germany, Austria and Switzerland - BERING CRC
ONCOL RES TREAT. 2022; 45(SUPPL 3): 64-64.
[Poster]
Web of Science
** Prietl, B; Odler, B; Kirsch, AH; Artinger, K; Eigner, M; Schmaldienst, S; Pfeifer, V; Stanzer, S; Eberl, A; Raml, R; Rosenkranz, A; Brodmann, M; Eller, P; Pieber, T; Eller, K
CHRONIC INFLAMMATION MIGHT PROTECT HAEMODIALYSIS PATIENTS FROM SEVERE COVID-19
NEPHROL DIAL TRANSPL. 2022; 37: I106-I106.
[Poster]
Web of Science
** Riedl, JM; Barth, D; Steinlechner, S; Moik, F; Posch, F; Schlintl, V; Mayer, MC; Sandner, AM; Berton, F; Koch, L; John, N; Wurm, R; Pichler, M; Absenger, G; Jost, PJ; Wohlkonig, C; Richtig, E; Winder, T; Gerger, A; Terbuch, A
Early CRP Kinetics after Initiation of Immune Checkpoint Inhibitors is a predictive Biomarker for Treatment Response independent of the Tumor Antity
ONCOL RES TREAT. 2022; 45(SUPPL 2):228-228.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; Okt 7-10, 2022; Wien.
[Poster]
Web of Science
** Robinson, I; Hochmair, MJ; Jansen, C; Pacifico, C; Sladek, B; Knabl, A; Gasche, N; Absenger, G; Pichler, M; Valipour, A
Prediction of immune checkpoint inhibitor (ICI) response in non-small cell lung cancer (NSCLC) patients using a microbiome-based biomarker
WIEN KLIN WOCHENSCHR. 2022; 134(19-20): 742-742.
[Poster]
Web of Science
** Robinson, I; Schmidinger, M; Hochmair, MJ; Ay, L; Absenger, G; Pichler, M; Nguyen, VAF; Richtig, E; Rainer, B; Jansen, C; Sladek, B; Knabl, A; Gasche, N; Valipour, A
BiomeOne: Multi-centric validation of a novel microbiome-based biomarker to predict response to cancer immunotherapy
ANN ONCOL. 2022; 33(7):S592-S592.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); SEP 09-13, 2022; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2022.07.149
[Poster]
Web of Science
FullText
FullText_MUG
** Ruhnke, L; Frimmel, J; Rollig, C; Mohr, B; Altmann, H; Poitz, D; Zukunft, S; Schranz, K; Vosberg, S; Spiekermann, K; von Bergwelt, M; Jost, E; Dressler, S; Schafer-Eckart, K; Chavakis, T; Aust, D; Johrens, K; Baretton, G; Bornhauser, M; Greif, PA; Stolzel, F; Herold, S; Wagenfuhr, L
Prevalence, Clinical and Molecular Features, and Prognostic Value of Tetraploidy/Near-Tetraploidy in Patients with Acute Myeloid Leukemia
BLOOD. 2022; 140: 3454-3455.
Doi: 10.1182/blood-2022-166271
Web of Science
FullText
FullText_MUG
** Schranz, A; Sternad, C; Mischinger, HJ; Wagner, D; Jost, PJ; Riedl, J; Wolfler, A; Pieber, T; Sourij, H; Aberer, F
Incidence of diabetes and its impact on survival after pancreatic tumor surgery - a retrospective data analysis
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):258-259.-Jahrestagung der Österreichischen Diabetesgesellschaft ;
[Poster]
Web of Science
** Singer, CF; Egle, D; Greil, R; Petru, E; Ohler, L; Balic, M; Tinchon, C; Pfeiler, G; Marhold, M; Brunner, C; Haider, K; Galid, A; Pluschnig, U; Haslbauer, F; Hubalek, M; Redl, A; Flatschacher, J; Uthman, S; Mraz, B; Bartsch, R
REACH AUT: Efficacy and safety of first-line (1L) ribociclib (RIB) plus endocrine therapy (ET) in HR+, HER2-metastatic breast cancer (MBC) from a real-world (RW) study: 3rd interim analysis
ANN ONCOL. 2022; 33: S217-S217.
Doi: 10.1016/j.annonc.2022.03.214
[Poster]
Web of Science
FullText
FullText_MUG
** Stintzing, S; Hubner, G; Schroder, J; Forstbauer, H; Kisro, J; Welslau, M; Muller-Huesmann, H; Burkle, D; Krammer-Steiner, B; von der Heyde, E; Reichenbach, F; Arnold, D; Fritsch, RM; Gerger, A; Hegewisch-Becker, S; Vogel, A; Wagner, AD; Winder, T; Koeberle, D; Prager, G
Baseline characteristics of patients enrolled in the BERING CRC study: A European real-world study in BRAF V600E-mutant metastatic colorectal cancer.
J CLIN ONCOL. 2022; 40(16): E15584-E15584.
[Poster]
Web of Science
** Stintzing, S; Von Weikersthal, L; Fuchs, M; Kaiser, F; Heinrich, K; Modest, DP; Hofheinz, R; Decker, T; Gerger, A; Angermeier, S; Rumpold, H; Dickhut, A; Ohler, L; Gruenberger, B; Niedersuess-Beke, D; Sandmann, M; Winder, T; Kasper, S; Prager, G; Heinemann, V
Randomized study to investigate a switch maintenance concept with 5-FU plus bevacizumab after FOLFIRI plus cetuximab induction treatment versus continued treatment with FOLFIRI plus cetuximab: Report of a secondary endpoint of the phase-III FIRE-4 study (AIO KRK-0114).
J CLIN ONCOL. 2022; 40(16):
[Poster]
Web of Science
** Szmyra, MM; Haingartner, S; Jantscher, S; Pansy, K; Uhl, B; Greinix, HT; Neumeister, P; Bernhart, E; Beham-Schmid, C; Dengler, MA; Klosch, B; Deutsch, AJA
The Flavonoid Brusatol Induces Apoptosis in Aggressive Lymphoma Cells and Exhibits Synergistic Effect with Venetoclax
BLOOD. 2022; 140: 4945-4946.
Doi: 10.1182/blood-2022-166678
[Poster]
Web of Science
FullText
FullText_MUG
** Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T
Thromboprophylaxis and its influence on the risk of thromboembolism in patients with germ cell tumors receiving cisplatin-containing chemotherapy
ONCOL RES TREAT. 2022; 45(SUPPL 2):322-322.
[Poster]
Web of Science
** Troelsen, FS; Vago, EK; Horvath-Puho, E; van Es, N; Mulder, FI; Moik, F; Erichsen, R; Ay, C; Sorensen, HT
KRAS mutation in colorectal cancer and risk of venous thromboembolism: a Danish population-based cohort study
THROMB RES. 2022; 213: S11-S11.-11th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC); MAY 27-29, 2022; Bergamo, ITALY.
[Oral Communication]
Web of Science
** Villalona-Calero, MA; Patnaik, A; Maki, RG; O'Neil, B; Abbruzzese, JL; Dagogo-Jack, I; Devarakonda, S; Wahlroos, S; Lin, CC; Fujiwara, Y; Terbuch, A; Postel-Vinay, S; Goebeler, ME; Addeo, A; Prenen, H; Arkenau, T; Sacher, AG; Liu, CX; Kormany, W; Ahnert, JR
Design and rationale of a phase 1 dose-escalation study of AMG 193, a methylthioadenosine (MTA)-cooperative PRMT5 inhibitor, in patients with advanced methylthioadenosine phosphorylase (MTAP)-null solid tumors
J CLIN ONCOL. 2022; 40(16):
[Poster]
Web of Science
** von der Heyde, E; Burkle, D; Forstbauer, H; Hubner, G; Schmidt, B; Schroder, J; Distelrath, A; Wierecky, J; Stubs, P; Kisro, J; Welslau, M; Muller-Huesmann, H; Gohler, T; Krammer-Steiner, B; Schwaner, I; Hering-Schubert, C; Gerger, A; Greil, R; Jacobasch, L; Reichenbach, F; Stintzing, S; Prager, G
Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal cancer: Update on the first real-world study in Germany and Austria BERING CRC
ANN ONCOL. 2022; 33: S248-S248.
Doi: 10.1016/j.annonc.2022.04.099
[Poster]
Web of Science
FullText
FullText_MUG
** Wagner, N; Lenders, MM; Kuhl, K; Reinhardt, L; Fuchss, M; Ring, N; Richtig, G; Ebel, C; Andre, F; Stager, R; Zellweger, C; Sturmer, SH; Lang, R; Paar, M; Gussek, P; Kimeswenger, S; Oellinger, A; Amaral, T; Forschner, A; Leiter-Stoppke, U; Weide, B; Gassenmaier, M; Schraag, A; Klumpp, B; Hoetzenecker, W; Ziemer, M; Berking, C; Mangana, J; Nguyen, VA; Terheyden, P; Richtig, E; Loquai, C; Diem, S; Cozzio, A; Rocken, M; Garbe, C; Gebhardt, C; Meier, F; Eigentler, T; Flatz, L
Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice
J DTSCH DERMATOL GES. 2022; 20: 3-4.-32. Deutschen Hautkrebskongresses (ADO‐Jahrestagung), 14.–17. September 2022; Sep 14-17, 2022; Hannover, Deutschland.
[Poster]
Web of Science
** Zacharias, M; Konjic, S; Absenger, G; Hochmair, MJ; Fabikan, H; Weinlinger, C; Illini, O; Jost, PJ; Schlintl, V; Wurm, R; Lindenmann, J; Fediuk, M; Brcic, L; Terbuch, A
Clinicopathological Features of Rare but Targetable Mutations in Surgically Resected Lung Carcinomas
J THORAC ONCOL. 2022; 17(9): S201-S202.
[Poster]
Web of Science
** Zgubic, JA; Zacharias, M; Wurm, R; Terbuch, A; Brcic, L
Predictive and prognostic relevance of PD-L1 and TIGIT expression in patients with non-small cell lung carcinoma treated with immunotherapy
HISTOPATHOLOGY. 2022; 81: 170-170.
[Poster]
Web of Science
Barth, D; Stradner, M; Hutterer, H; Spiegelberg, J; Bauernhofer, T; Absenger, G; Jost, P; Pichler, M
Blood-based B-cell subtypes as predictors of treatment response during treatment with immune checkpoint inhibitors: a prospective longitudinal pan-cancer study.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology 2022. 2022; -OeGHO Frühjahrstagung 2022; APR 8-10, 2022; Graz, AUSTRIA.
[Poster]
El-Heliebi, A; Prietl, B; Mahdy-Ali, K; Purkart, TU; Moazzami, A; Leoni, M; Gerlitz, L; Skofler, C; Stanzer, S; Franz, J; Harbusch, N; Madl, T; Wadiura, L; Peilnsteiner, T; Widhalm, G; Rössler, K; Tomberger, M; Mattersdorfer, K; Her, NG; Nam, DH; Kroneis, T; Oberhuber, M; Pieber, TR
Next generation drug screening platform: generation of patient derived cells for ex vivo drug response studies of gliomas
10.1093/neuonc/noac174.180. 2022; 24(SI):-17th Meeting of the European Association of Neuro-Oncology; SEP 15-18, 2022; Vienna, AUSTRIA.
[Poster]
Huemer, M; Jahn-Kuch D; Hofmann, G; Andritsch, E; Farkas C; Schaupp, W; Masel EK; Jost JP; Pichler M
Trends of public interest in palliative care, euthanasia, and advanced health care directives in Austria, Germany, and Switzerland using big data from Google
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. 2022; 22(3):17-17.-OeGHO & AHOP Frühjahrstagung; APR 8-10, 2022; Graz, AUSTRIA.
[Poster]
FullText
Jernej, L; Smolle, M; Lohberger, B ; Leithner, A; Bergovec, M; Liegl-Atzwanger, B; Szkandera, J; Brcic, I
Erfolg und Sicherheit der Denosumab-Therapie bei Riesenzelltumoren des Knochens.
Abstract Book 21/22. 2022; -1. Österreichischer Kongress für Orthopädie und Traumatologie; 12-14.05.2022; Graz.
[Poster]
Klec, C; Knutsen, E; Pasculli, B; Krajina, K; Deutsch, A; Perander, M; Graier, WF; Parrella, P; Pichler, M
The RNA-binding protein ALYREF is promoting triple negative breast carcinogenesis through CPSF6-mediated selective regulation of the short NEAT1 isoform
OeGHO- & AHOP-Frühjahrstagung 2022. 2022; -ÖGHO Frühjahrtagung ; APR 8-10, 2022; Graz, AUSTRIA.
[Poster]
Klec, C; Stotz, M; Vychytilova-Faltejskova, P; Slaby, O; Gerger, A; Pichler, M
ALYREF regulates glucose metabolism and tumorigenesis in colorectal cancer
OeGHO- & AHOP-Frühjahrstagung 2022. 2022; -ÖGHO Frühjahrstagung; APR 8-10, 2022; Graz, AUSTRIA.
[Poster]
Krajina, K; Kapeller, A; Dengler, M; Jost, P; Pichler, M; Klec, C
The long non-coding RNA NORAD and its relevance on PARP inhibitor sensitivity in triple negative breast cancer
Proceedings of the Annual Meeting of the Austrian Society
of Haematology and Medical Oncology. 2022; -OeGHO- & AHOP-Frühjahrstagung 2022; APR 8-10, 2022; Graz, AUSTRIA.
[Poster]
Lindenmann, J; Fink-Neuboeck, N; Fediuk, M; Porubsky, Ch; Absenger, G; Mykoliuk, I; Brcic, L; Anegg, U; Maier, A; Jost, P; Smolle, J; Smolle-Juettner, FM
Recurrence and survival following surgery of T3 esophageal carcinoma with curative intent. Role of circumferential resection margin.
European Surgrey- ACA. 2022; 54: 50-50.-63. Österreichischer Chirurgenkongress; JUN 15-17, 2022; Graz, AUSTRIA.
[Oral Communication]
Mischinger, J; Schoellnast, H; Zurl, H; Geyer, M; Fischereder, K; Scheipner, L; Jasarevic, S; Adelsmayr, G; Igrec, J; Fritz, G; Merdzo-Hörmann, M; Elstner, J; Schmid, J; Triebl, A; Reiter, C; Steiner, J; Rosenlechner, D; Seles, M; Pichler, G; Pichler, M; Riedl, J; Schöpfer-Schwab, S; Hutterer, G; Zigeuner, R; Augustin, H; Ahyai, S; Mannweiler, S; Fuchsjäger, M; Talakic, E
Combining targeted and systematic transrectal ultrasound guided prostate biopsy to improve verifcation and reduce misclassifcation of prostate cancer
Die Urologie 2022, 61 (Suppl 3):S159.
. 2022; -74. Kongress der Deutschen Gesellschaft für Urologie e.V.; 21.-24.09.2022; CCH Congress Center Hamburg, Deutschland.
[Oral Communication]
Mischinger, J; Schöllnast, H; Zurl, H; Geyer, M; Fischereder, K; Adelsmayr, G; Igrec, J; Fritz, GA; Merdzo-Hörmann, M; Elstner, J; Schmid, J; Triebl, A; Trimmel, V; Reiter, C; Steiner, J; Rosenlechner, D; Seles, M; Pichler, G; Pichler, M; Riedl, JM; Schöpfer-Schwab, S; Strobl, J; Hutterer, G; Zigeuner, R; Pummer, K; Augustin, H; Ahyai, S; Mannweiler, S; Fuchsjäger, M; Talakic, E
MRT gezielte Fusionsbiopsie der Prostata vs. systematische transrektale ultraschallgezielte Biopsie vs. kombiniertes Biopsieverfahren zur Detektion und korrekten Klassifikation des Prostatakarzinoms: eine retrospektive Kohortenstudie
German Medical Science GMS Publishing House; 2022. Doc22urobay38. doi: 10.3205/22urobay38. 2022; -48. Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie
; 19.-21.05.2022; Inselhalle Lindau, Deutschland.
[Oral Communication]
Mykoliuk, I; Lindenmann, J; Fink-Neuboeck, N; Fediuk, M; Porubsky, Ch; Terbuch, A; Absenger, G; Brcic, L; Anegg, U; Maier, A; Smolle, J; Smolle-Juettner, FM
Perioperative complications in esophagectomy for carcinoma are correlated to a higher recurrence rate.
European Surgery- ACA. 2022; 54: 67-68.-63. Österreichischer Chirurgenkongress; JUN 15-17, 2022; Graz, AUSTRIA.
[Oral Communication]
Okresa, L; Lindenmann, J; Fink-Neuboeck, N; Fediuk, M; Mykoliuk, I; Terbuch, A; Absenger, G; Roj, A; Anegg, U; Maier, A; Smolle, J; Smolle-Juettner, FM
Esophagectomy in octogenarians – a worthwhile indication?
European Surgery- ACA. 2022; 54: 124-124.-63. Österreichischer Chirurgenkongreß; JUN 15-17, 2022; Graz, AUSTRIA.
[Poster]
Richtig, G; Kienzl, M; Rittchen, S; Roula, D; Eberel, J; Sarif, Z; Pichler, M; Hoefler, G; Heinemann, A
Cannabinoids reduce melanoma cell viability and do not interfere with commonly used targeted therapy in metastatic melanoma.
Proceedings of the Annual Meeting of the Austrian Society
of Haematology and Medical Oncology. 2022; -OeGHO- & AHOP-Frühjahrstagung 2022; APR 8-10, 2022; Graz, AUSTRIA.
[Poster]
FullText
Sauseng, S; Imamovic, A; Kornprat, P; Waha, JE; Schemmer, P; Mischinger, HJ; Pichler, M
Is the new R0 resection the crucial corner stone within interdisciplinary therapy regimes to reach a prolonged OAS for PDAC patients
European Journal of Surgical Oncology. 2022; 48(2):134-134.-Congress of the European Society of Oncological Surgery; Nov 7-10, 2021; Lissabon.
[Oral Communication]
FullText
Scheipl, S; Brcic, I; Moser, T; Fischerauer, S; Riedl, J; Bergovec, M; Smolle, M; Posch, F; Gerger, A; Pichler, M; Stöger, H; Leithner, A; Heitzer, E; Liegl, B; Szkandera, J
Die molekularpathologische Testung von Weichteilsarkomen mittels FoundationOne® Heme bestätigt potentielle therapeutische Targets: Ergebnisse einer monozentrischen Analyse
Abstractband 1. Österreichischer Kongress für Orthopädie & Traumatologie. 2022; -1. Österreichischer Kongress für Orthopädie & Traumatologie; 12.-14. Mai, 2022; Graz, Austria.
[Poster]
Seidel, M; Leithner, A; Kashofer, K; Moser, T; Thueringer, A; Liegl-Atzwanger, B; Szkandera, J; Benesch, M; El-Heliebi, A; Heitzer, E
Ewing sarcoma and liquid biopsy: plasma ctDNA quantification by ddPCR for monitoring residual disease
21st General Meeting of the International Society of Limb Salvage; IL5. 2022; 11-11.-21st General Meeting of the International Society of Limb Salvage; SEP 6-9, 2022; Los Angeles, USA.
[Oral Communication]
Seidel, MG; Leithner, A; Kashofer, K; Moser, T; Theuringer, A; Liegl-Atzwanger, B; Benesch, M; Szkandera, J; El-Heliebi, A; Heitzer, E
Liquid biopsy for monitoring paediatric Ewing sarcoma patients.
Abstract Book of the 34th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS). 2022; 27--34th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS); OCT 17-19, 2022; London, GREAT BRITAIN.
[Oral Communication]
Smolle, M; van de Sande, M; Callegaro, D; Wunder, J; Hayes, A; Leitner, L; Bergovec, M; Tunn, PU; Panotopoulos, J; Willegger, M; Windhager, R; Leithner, A; Haas, R; Szkandera, J
Szkandera
Entwicklung eines individuellen Nachsorgeschemas für Patienten mit primär lokalisierten, G2 und G3 Weichteilsarkomen der Extremitäten
Abstractband 1. Österreichischer Kongress für Orthopädie & Traumatologie. 2022; 48--1. Österreichischer Kongress für Orthopädie & Traumatologie; MAY 12-14, 2022; Graz, AUSTRIA.
[Oral Communication]
Smolle, M; van de Sande, M; Tunn, PU; Hayes, A; Bergovec, M; Willegger, M; Windhager, R; Szkandera, J; Leithner, A
Analyse der prognostischen Vorhersagekraft der 7. und 8. Version der AJCC-Klassifikation für Weichteilsarkome
Abstractband 1. Österreichischer Kongress für Orthopädie & Traumatologie. 2022; -1. Österreichischer Kongress für Orthopädie & Traumatologie; 12.-14. Mai, 2022; Graz, Austria.
[Oral Communication]
Smolle, MA; Helmberg, W; Barth, DA; Sareban, N; Szkandera, J; Liegl-Atzwanger, B; Leithner, A; Pichler, M
Prognostic Effect Of Allogeneic Red Blood Cell Transfusions In Soft Tissue Sarcoma Patients. A Retrospective Study.
Advanced Scientific Programme EFORT Congress. 2022; -EFORT Annual Congress; JUN 22-24, 2022; Lisbon, PORTUGAL.
[Oral Communication]
Smolle, MA; Helmberg, W; Barth, DA; Sareban, N; Szkandera, J; Liegl-Atzwanger, B; Leithner, A; Pichler, M
Einfluss der perioperativen Erythrozytenkonzentrat-Gabe auf die Prognose von Weichteilsarkom-patient*Innen. Eine retrospektive Studie.
Abstractband DKOU 2022. 2022; -Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU); OCT 25-28, 2022; Berlin, GERMANY.
[Oral Communication]
Smolle, MA; Kogler, A; Friesenbichler, J; Bergovec, M; Castellani, C; Till, H; Benesch, M; Szkandera, J; Smolle-Jüttner, FM; Leithner, A
Impact of pulmonary metastasectomy on outcome of bone sarcoma patients with lung metastases. A retrospective, IPTW- weighted analysis.
Abstract book of the 21st General Meeting of the International Society of Limb Salvage. 2022; -21st General Meeting of the International Society of Limb Salvage; SEP 6-9, 2022; Los Angeles, USA.
[Oral Communication]
Smolle, MA; Musser, E; Bergovec, M; Friesenbichler, J; Wibmer, CL; Leitner, L; Sorensen MS; Petersen, MM; Brcic, I; Szkandera, J; Scheipl, S; Leithner, A
External validation of the 2013-spring model for survival prediction in surgically treated patients with metastases to the appendicular skeleton.
Abstract Book of EMSOS 2022. 2022; -34th Annual Meeting of the European Musculo Skeletal Oncology Society; OCT 17-19, 2022; London, UNITED KINGDOM.
[Oral Communication]
Smolle, MA; Van De Sande, M; Jeys, L; Bonenkamp, H; Pollock, R; Keller, Johnny; Tunn, PU; Haas, R; Van Ginkel, RJ; Verhoef, C; Leithner, A; Szkandera, J
Impact Of Neoadjuvant And Adjuvant Radiotherapy On The Outcome Of Soft Tissue Sarcoma Patients. A Retrospective, Multicentre Study.
Advanced Scientific Programme EFORT Annual Congress. 2022; -EFORT Annual Congress; JUN 22-24, 2022; Lisbon, PORTUGAL.
[Oral Communication]
Smolle, MA; van de Sande, M; Tunn, PU; Hayes, A; Bergovec, M; Smith HG; Niethard, M; Windhager, R; Szkandera, J; Leithner, A
Prognostic accuracy of 7th and 8th AJCC classification for soft tissue sarcomas. Results from a retrospective, multi-centre study.
Abstract book of the 21st General Meeting of the International Society of Limb Salvage. 2022; -21st General Meeting of the International Society of Limb Salvage; SEP 6-9, 2022; Los Angeles, USA.
[Oral Communication]
Vosberg, S; Kerbs, P; Spiekermann, K; Greif, P
DNA methylation profling reveal mechanisms of relapse specifc gene expression in acute myeloid leukemia
memo - Magazine of European Medical Oncology volume 15, pages37–67 (2022). 2022; -Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 8-10, 2022; Graz.
[Poster]
Vosberg, S; Ohnmacht, A; Moser, C; Arneth, A; Jurinovic, V; Metzeler, KH; Sauerland, MC; Görlich, D; Berdel, WE; Braess, J; Amler, S; Krug, U; Hiddemann, W; Spiekermann, K; Oakes, CC; Menden, MP; Herold, T; Greif, PA
DNA Methylation Profiling Refines The Prognostic Classification Of Acute Myeloid Leukemia Patients Treated With Intensive Chemotherapy
Hemasphere. 2022 Jun; 6(Suppl ): 1-4130.. 2022; -27th Annual Meeting of the European Hematology Association; JUN 9-12, 2022; Wien.
[Poster]
Zügner, E; Prugger, EM; Schimek, D; El-Heliebi, A; Prietl, B; Gerlitz, L; Skofler, C; Stanzer, S; Franz, J; Harbusch, N; Tomberger, M; Mattersdorfer, K; Kroneis, T; Oberhuber, M; Pieber, TR; Magnes C.
Metabolic profiling of drug treatment responses in drug sensitive and drug resistant glioblastoma cells
Proceedings of Metabolomics 2022. 2022; -Metabolomics 2022; Jun, 19-23, 2022; Valencia, SPAIN.
[Poster]
Originalbeiträge in Sammelwerk (Buch)
Barth, DA; Pichler, M;
Pathophysiology roles and translational opportunities of miRNAs in Renal cancer.
In: Negrini, M; Calin, GA; Croce, C; editors(s). MicroRNA in Human Malignancies. Elsevier; 2022(ISBN: 9780128222874)
Vortrag/Präsentation vor Nicht-Fachpublikum (Science to Public)
Huemer, M
Sterbehilfe "Aktueller Stand der Diskussion"
8. steirischer Krebstag; SEP 10, 2022; Graz, AUSTRIA. 2022.
[Science to Public]